Article ID Journal Published Year Pages File Type
5699420 Clinical Oncology 2010 5 Pages PDF
Abstract
Although continuous research is necessary to identify patients who can be managed safely and palliated without WBRT, we feel that a model of the BSBM unfavourable group (Karnofsky performance status <80, uncontrolled primary tumour and presence of extracranial metastases) and no intent to treat systemically might form a basis for validation in other large databases. The triple-negativity criterion was not superior for predicting poor prognosis.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , ,